Our publications
Patent families
1) WO2021080427A1: CHIMERIC POLYPEPTIDE FOR REGULATING IMMUNE CELLS
2) WO2023177296A1: Zinc finger degron sequences
3) WO2024117904A1: Receptor- and drug-dependent regulated on-site production of biologicals.
4) WO2025248464A3: Loop reinforcement expression system for improved cell therapy products.
Papers
1) CRASH-IT switch enables reversible and dose-dependent control of TCR and CAR T-cell function. Cancer Immunology Research
2) Multimodular Optimization of Chemically Regulated T Cell Switches Demonstrates Flexible and Interchangeable Nature of Immune Cell Signaling Domains. Human Gene Therapy
3) Safety switches for adoptive cell therapy. Current Opinion in Immunology